These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6927288)

  • 1. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
    Hof H; Sticht-Groh V; Müller KM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):332-3. PubMed ID: 6927288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of GO 10213, a nitroimidazole derivative.
    Hof H; Ströder J
    Antimicrob Agents Chemother; 1986 May; 29(5):953-4. PubMed ID: 3729357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazole.
    Freydière AM; Gille Y; Tigaud S; Vincent P
    Antimicrob Agents Chemother; 1984 Jan; 25(1):145-6. PubMed ID: 6703680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.
    Hof H; Sticht-Groh V
    Infection; 1984; 12(1):36-9. PubMed ID: 6706411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H; Rieffert M; Sticht-Groh V; Zak O; Schweizer EH
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species.
    Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC
    Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of metronidazole and niridazole against Trichomonas vaginalis clinical isolates.
    Yarlett N; Hof H; Yarlett NC
    J Antimicrob Chemother; 1987 Jun; 19(6):767-70. PubMed ID: 3497149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.
    Goldstein EJ; Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1978 Oct; 14(4):609-13. PubMed ID: 718156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.
    Chow AW; Patten V; Guze LB
    J Infect Dis; 1975 Feb; 131(2):182-5. PubMed ID: 163867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vitro activity of niridazole, metronidazole and tetracycline against subgingival bacteria in chronic periodontitis.
    Wade WG; Addy M
    J Appl Bacteriol; 1987 Nov; 63(5):455-7. PubMed ID: 3440767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of the antibacterial action of metronidazole against vibrios and Campylobacter (author's transl)].
    Füzi M
    Zentralbl Bakteriol A; 1981; 249(2):242-6. PubMed ID: 7269853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronidazole resistance and microaerophily in Campylobacter species.
    Smith MA; Jorgensen MA; Mendz GL; Hazell SL
    Arch Microbiol; 1998 Oct; 170(4):279-84. PubMed ID: 9732442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Bacteriostatic synergism studies.
    Werner H; Schädler G; Krasemann C
    Arzneimittelforschung; 1983; 33(4):574-7. PubMed ID: 6683537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["In vitro" susceptibility of some aerobic and anaerobic bacteria to three 5-nitro-imidazole derivatives: metronidazole, ornidazole and tinidazole (author's transl)].
    Dublanchet A; Durieux R
    Ann Microbiol (Paris); 1980; 131(1):45-59. PubMed ID: 7362180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete anaerobiosis as a cause of metronidazole 'resistance'.
    Milne SE; Stokes EJ; Waterworth PM
    J Clin Pathol; 1978 Oct; 31(10):933-5. PubMed ID: 213449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of niridazole by metronidazole resistant and susceptible strains of Trichomonas vaginalis.
    Yarlett N; Rowlands CC; Yarlett NC; Evans JC; Lloyd D
    Parasitology; 1987 Feb; 94 ( Pt 1)():93-9. PubMed ID: 3029651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro activity of the combination of daptomycin and metronidazole against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus spp., and Bacteroides spp.
    Werner H; Nagy E; Heizmann WR
    J Chemother; 1989 Jul; 1(4 Suppl):207-8. PubMed ID: 16312371
    [No Abstract]   [Full Text] [Related]  

  • 19. The aerobic activity of metronidazole against anaerobic bacteria.
    Dione N; Khelaifia S; Lagier JC; Raoult D
    Int J Antimicrob Agents; 2015 May; 45(5):537-40. PubMed ID: 25813393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Common pathogens of surgical infections and their drug sensitivities].
    Zhang YP
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):215-6, 253. PubMed ID: 2805989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.